Who
COLUMN GROUP III GP, LP
10% owner
Company insider
Files Form 4 as: 10% owner, Tenaya Therapeutics; 10% owner, Surrozen; 10% owner, Constellation Pharmaceuticals; Insider, Ngm Biopharmaceuticals; Insider, Revolution Medicines.
In numbers
- Trades disclosed
- 62
- Buys
- 24
- Sells
- 6
- Bought
- $13.5M
- Sold
- $5.9M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 22 Oct 2019
- Last trade
- 25 Feb 2026
- Last filed
- 26 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Feb 2026filed 26 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $928K1,649,281 at $0.5624 | filing |
| 25 Feb 2026filed 26 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.0M1,862,545 at $0.5624 | filing |
| 24 Feb 2026filed 26 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $190K309,228 at $0.6153 | filing |
| 24 Feb 2026filed 26 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $215K349,212 at $0.6153 | filing |
| 23 Feb 2026filed 24 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $86K143,709 at $0.5972 | filing |
| 23 Feb 2026filed 24 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $97K162,291 at $0.5972 | filing |
| 20 Feb 2026filed 24 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $151K245,965 at $0.6149 | filing |
| 20 Feb 2026filed 24 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $171K277,769 at $0.6149 | filing |
| 11 Feb 2026filed 12 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.3M1,905,115 at $0.6808 | filing |
| 11 Feb 2026filed 12 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.5M2,151,458 at $0.6808 | filing |
| 10 Feb 2026filed 12 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $132K161,422 at $0.8161 | filing |
| 10 Feb 2026filed 12 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $149K182,295 at $0.8161 | filing |
| 20 Jan 2026filed 20 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $166K8,484 at $19.60 | filing |
| 20 Jan 2026filed 20 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $188K9,568 at $19.60 | filing |
| 16 Jan 2026filed 20 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $24K1,204 at $20.00 | filing |
| 16 Jan 2026filed 20 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $27K1,358 at $20.00 | filing |
| 15 Jan 2026filed 20 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $111K5,590 at $19.89 | filing |
| 15 Jan 2026filed 20 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $125K6,303 at $19.89 | filing |
| 14 Jan 2026filed 15 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $52K2,596 at $19.99 | filing |
| 14 Jan 2026filed 15 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $59K2,927 at $19.99 | filing |
News
Head to Head Review: Surrozen (NASDAQ:SRZN) vs. AbCellera Biologics (NASDAQ:ABCL)SRZN · tickerreport.com · 14 Oct 2026Surrozen Sees Unusually Large Options Volume (NASDAQ:SRZN)SRZN · themarketsdaily.com · 12 Oct 2026Head to Head Analysis: Whitehawk Therapeutics (NASDAQ:WHWK) vs. Surrozen (NASDAQ:SRZN)SRZN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name COLUMN GROUP III GP, LP; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.